Latest News
The Next Recruitment Challenge Isn’t Awareness, It’s Qualification
For years, the clinical research industry has focused heavily on one question: How do we reach more patients? Digital advertising, social media campaigns, patient advocacy partnerships, and online recruitment platforms have dramatically expanded researchers' ability...
Latest News
Next-Gen 3D Models: A Webinar on Elevating Brain Organoid Fidelity
Human brain organoids have fundamentally shifted the paradigm of neurological research. By transforming human pluripotent stem cells (hPSCs) into self-organizing, three-dimensional tissues, these models provide an unprecedented window into the distinct spatial...
Weekly News Roundup | 20 July 2026
Life science news 20 July 2026: the FDA approves the first oral PCSK9 inhibitor for high cholesterol, Eli Lilly makes the largest psychedelics deal in Big Pharma history, and a first-in-class breast cancer therapy wins regulatory clearance in a landmark week for...
The NewCo Model: How Big Pharma Spins Out Pipeline Assets
The NewCo model biopharma strategy has rapidly become one of the most consequential dealmaking trends in the life sciences industry. Rather than shelving deprioritised pipeline assets or selling them outright through traditional licensing agreements, major...
Diranersen: First Tau Drug to Show Cognitive Benefit in Alzheimer’s
The first Phase 2 clinical evidence that a tau Alzheimer's drug can simultaneously reduce brain tangles and slow cognitive decline was presented at the Alzheimer's Association International Conference (AAIC) 2026 in London on 14 July. Biogen's diranersen, an antisense...
Join The Future Of Life Sciences Media
In a world overflowing with information, LifeScienceDaily.news stands apart as the dedicated space where life sciences professionals share what’s new, what’s next, and why it matters — all in real time.
Don’t wait for the media to pick up your story. Be the media.
Trending
More News
Protecting R&D and Clinical Trial Data in the Age of AI
Drug development is one of the most expensive and time-intensive innovation processes in the world. Estimates from the Tufts Center for the Study of Drug Development suggest that bringing a new drug to market can cost over $2.6 billion and take more than a decade of...
Medical Writers Become Strategic Partners
In regulated drug development, documentation shapes how a program is understood long before regulators ever see it. Protocols, investigator brochures, integrated summaries, and submission-ready modules establish the scientific and strategic narrative of a development...
HIV Treatment Revolution: Infected Cells Now Trigger Their Own Elimination
Imagine a virus so cunning it hides in your body's own cells, evading detection for decades while you take daily pills just to keep it at bay. That's the reality for nearly 40 million people living with HIV worldwide. But what if we could flip the script—turning those...
Microplastics From Food Packaging Linked to Liver Damage, New Study Finds
New research has found that microplastics from food packaging could cause damage to the normal function and health of the liver. Microplastics - small fragments less than 5mm in size - are already known to be widespread in the food and drink that we consume. It is...
Weekly News Roundup | 16 March 2026
Your essential life science news digest: the past week's biggest stories in pharma, biotech and healthcare. 👇 This week's life science news was defined by regulatory uncertainty and clinical momentum. A landmark FDA leadership departure sent rare disease stocks...
Imperial, Oxford & GSK launch £11M Digital Twin Organ Centre
Imperial College London, University of Oxford and GSK Launch £11 Million Centre to Build Digital Twins of Human Organs A new research centre backed by £11 million in funding has been established by Imperial College London, the University of Oxford and GSK to develop...
Reflections and Healing at the End of Life
Words To Begin At age 81, the author has lived a "life of letters" (perhaps three million words) addressing a wide variety of subjects during multiple careers: Systems Engineering (PhD at UCLA in 1976), Military Science (21 years on active duty, in high-tech...
Why Fertility Diagnostics Must Move to Continuous Remote Monitoring
In cardiology and diabetes, we no longer rely on single, in-clinic readings to diagnose complex conditions; instead, remote monitors are used to capture data over a period of time. We’ve seen that the standard of care across medicine is shifting from episodic...
The Microbiome: The Missing Layer in Modern Metabolic Care
Over the last decade, obesity management has undergone a structural transformation. What was once a field dominated almost exclusively by bariatric surgery has evolved into a far more nuanced metabolic discipline. The rise of GLP-1 receptor agonists and dual incretin...
Redefining Fertility & Modern Motherhood with Dr. Roohi Jeelani and Hayley
For many modern women, the concept of fertility is something to consider later, when life feels steady and the timing feels right. Now more than ever, trends that encourage delaying partnership, questioning traditional paths, or seeking information earlier are...
FDA Overhauls Pharmacokinetic Study Requirements
FDA Overhauls Pharmacokinetic Study Requirements in New Biosimilar Draft Guidance The US Food and Drug Administration (FDA) has overhauled biosimilar pharmacokinetic study requirements in new draft guidance issued on 9 March 2026, aimed at further reducing the time...
Breakthroughs in the Lab – Blind Spots in Reality
Obesity care is at a turning point. GLP-1s like Ozempic and Mounjaro have upended weight loss culture – and the research backs them up. For the first time, multiple randomized trials have found that anti-obesity medications can lead to an average 15-20% weight loss....
Protecting R&D and Clinical Trial Data in the Age of AI
Drug development is one of the most expensive and time-intensive innovation processes in the world. Estimates from the Tufts Center for the Study of Drug Development suggest that bringing a new drug to market can cost over $2.6 billion and take more than a decade of...
Medical Writers Become Strategic Partners
In regulated drug development, documentation shapes how a program is understood long before regulators ever see it. Protocols, investigator brochures, integrated summaries, and submission-ready modules establish the scientific and strategic narrative of a development...
HIV Treatment Revolution: Infected Cells Now Trigger Their Own Elimination
Imagine a virus so cunning it hides in your body's own cells, evading detection for decades while you take daily pills just to keep it at bay. That's the reality for nearly 40 million people living with HIV worldwide. But what if we could flip the script—turning those...
Microplastics From Food Packaging Linked to Liver Damage, New Study Finds
New research has found that microplastics from food packaging could cause damage to the normal function and health of the liver. Microplastics - small fragments less than 5mm in size - are already known to be widespread in the food and drink that we consume. It is...
Weekly News Roundup | 16 March 2026
Your essential life science news digest: the past week's biggest stories in pharma, biotech and healthcare. 👇 This week's life science news was defined by regulatory uncertainty and clinical momentum. A landmark FDA leadership departure sent rare disease stocks...
Imperial, Oxford & GSK launch £11M Digital Twin Organ Centre
Imperial College London, University of Oxford and GSK Launch £11 Million Centre to Build Digital Twins of Human Organs A new research centre backed by £11 million in funding has been established by Imperial College London, the University of Oxford and GSK to develop...
Reflections and Healing at the End of Life
Words To Begin At age 81, the author has lived a "life of letters" (perhaps three million words) addressing a wide variety of subjects during multiple careers: Systems Engineering (PhD at UCLA in 1976), Military Science (21 years on active duty, in high-tech...
Why Fertility Diagnostics Must Move to Continuous Remote Monitoring
In cardiology and diabetes, we no longer rely on single, in-clinic readings to diagnose complex conditions; instead, remote monitors are used to capture data over a period of time. We’ve seen that the standard of care across medicine is shifting from episodic...
The Microbiome: The Missing Layer in Modern Metabolic Care
Over the last decade, obesity management has undergone a structural transformation. What was once a field dominated almost exclusively by bariatric surgery has evolved into a far more nuanced metabolic discipline. The rise of GLP-1 receptor agonists and dual incretin...
Redefining Fertility & Modern Motherhood with Dr. Roohi Jeelani and Hayley
For many modern women, the concept of fertility is something to consider later, when life feels steady and the timing feels right. Now more than ever, trends that encourage delaying partnership, questioning traditional paths, or seeking information earlier are...
FDA Overhauls Pharmacokinetic Study Requirements
FDA Overhauls Pharmacokinetic Study Requirements in New Biosimilar Draft Guidance The US Food and Drug Administration (FDA) has overhauled biosimilar pharmacokinetic study requirements in new draft guidance issued on 9 March 2026, aimed at further reducing the time...
Breakthroughs in the Lab – Blind Spots in Reality
Obesity care is at a turning point. GLP-1s like Ozempic and Mounjaro have upended weight loss culture – and the research backs them up. For the first time, multiple randomized trials have found that anti-obesity medications can lead to an average 15-20% weight loss....
Featured Articles
Further News
Rethinking the Male Factor in IVF: Why New Sperm Technologies Matter
For much of the history of in-vitro fertilisation (IVF), technological advances have focused overwhelmingly on the egg and the embryo. Advances in ovarian stimulation protocols, time-lapse embryo imaging, genetic testing and cryopreservation have dramatically improved...
Why Pharma’s Commercial Model is Failing Precision Medicine
Pharma generates more insight than ever. Translating that insight into timely action is where the system falters, and the gap runs deeper than most commercial leaders are willing to admit. Over the past decade, omnichannel systems have matured considerably. CRM...
Teaching Children Conscious Self-Regulation for Life Outcomes
A Neurodevelopmental Framework for Strategic Life Construction In an era defined by rapid technological change, algorithmic persuasion, and rising rates of youth anxiety, the question is no longer whether children need education, but what kind of education is most...
Why Amazing Medical Technologies Fail (And How to Ensure Yours Doesn’t)
Have you considered what it means to have an FDA-approved, life-changing, medical product? It’s nothing short of amazing! However, let me add on to that question, have you considered what it means to have an FDA-approved, life changing, medical product WITHOUT a...
Making Pre-Commercial Marketing Technology Work Under Launch Pressure
In pre-commercial life sciences environments, marketing technology (MarTech) platforms are often implemented well before launch. Teams select, configure, and integrate systems quickly, expecting campaigns to perform flawlessly. But small gaps in governance, ownership,...
Thermo Fisher Scientific Opens New Distribution Center in Ireland
70,000 sq. ft. facility expands the company's biopharma, chemical and cold chain storage capacities DUBLIN, Ireland, (March 6, 2026) - Thermo Fisher Scientific Inc, the world leader in serving science, today announced the opening of a new, 70,000 sq.ft. distribution...
The Microbiome, as a Performance Regulator: Gut Integrity Under Physiological Load
In high-performance populations — elite athletes, tactical operators, founders, executives under sustained cognitive load — resilience is typically framed in terms of cardiovascular output, muscular strength, mitochondrial density or hormonal optimisation. Yet one of...
From Living Room to Lab: New Dementia Study to Close Participation Gap
People living with dementia will help close a long-standing weakness in research - the clinical trial evidence gap - in a new home-based study. While those over 65 account for two-thirds of illness in the UK, they make up just one-third of trial participants. This...
Why a New Era of Medical Innovation is Taking Shape
Over the next decade, modern medicine is poised to undergo a redefinition that has not been seen in generations. The surge in innovation, transformational scientific discoveries and rapidly maturing technologies is redefining patient outcomes. The biotech industry is...
Activating Autophagy, Your Body’s Natural Metabolic Superpower
Did you know that your body has its own biological process for clearing out old or damaged cells, and recycling dysfunctional components to prioritize healthier, more productive ones? For billions of years, autophagy has acted as a kind of evolutionary survival...
Beyond the Basics: How Behavioral Intelligence and ML Reduce Trial Dropout
Medication non-adherence and dropout have long been labeled “known problems” in the clinical trial space. Yet despite years of tinkering with the formula, these challenges have only become “well-known problems.” Operational efficiencies and innovation, digital...
Why Health Platforms Built for Millennials Will Fail Gen Alpha
The first smartphone-native generation expects fundamentally different things from digital health and retrofitting won't work Gen Alpha (born roughly between 2010 and 2024) is the first generation to grow up entirely in a world where smartphones, AI assistants, and...
Further News
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.
Don’t wait for the media to pick up your story. Be the media.
See More Articles
Want to Be Part of the Next Chapter in Life Sciences Media?
LifeScienceDaily.news is building a new kind of platform where innovators, researchers, and industry leaders tell their own stories and shape the narrative of what’s next in life sciences. Share your story and lead the conversation.